Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary hyperoxaluria type 2 × Endocrine × 90 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 73 Pheochromocytoma 26 Thyroid Cancer, Papillary 23 Paraganglioma 22 Carcinoma, Neuroendocrine 22 Thyroid Neoplasms 20 Adrenocortical Carcinoma 19 Pituitary Neoplasms 16 Neoplasms 14 Multiple Endocrine Neoplasia Type 1 14 Adenoma, Islet Cell 13 Neoplasm Metastasis 11 Gastro-enteropancreatic neuroendocrine tumor 11 Carcinoma, Hepatocellular 11 Breast Neoplasms 11 Sarcoma 10 Melanoma 10 Carcinoma, Non-Small-Cell Lung 10 Carcinoid Tumor 10 Thyroid Carcinoma, Anaplastic 9 Prostatic Neoplasms 9 Neuroblastoma 9 Lung Neoplasms 9 Carcinoma, Renal Cell 9 Brain Neoplasms 9 Adrenal Gland Neoplasms 9 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Colorectal Neoplasms 8 Adenocarcinoma, Follicular 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡